6.18
price down icon4.33%   -0.28
after-market Handel nachbörslich: 6.30 0.12 +1.94%
loading

Finanzdaten der 4 D Molecular Therapeutics Inc-Aktie (FDMT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
7.14%
0.015
0.014 0.001 0.003 0.005
Operating Expenses
10.88%
59.47
53.63 56.12 51.13 42.46
Benefits Costs and Expenses
100.00%
-
47.99 49.67 - -
Costs And Expenses
23.93%
59.47
47.99 49.67 51.13 42.46
Depreciation and Amortization
10.94%
1.166
1.051 1.096 1.19 1.194
Operating Income/Loss
10.88%
-59.46
-53.62 -56.12 -51.13 -42.46
Nonoperating Income/Loss
15.06%
4.798
5.649 6.446 7.289 7.503
Income/Loss From Continuing Operations Before Tax
100.03%
0.015
-47.97 -49.67 0.003 -34.95
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
13.94%
-54.66
-47.97 -49.67 -43.84 -34.95
Net Income/Loss
13.94%
-54.66
-47.97 -49.67 -43.84 -34.95
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.33%
55.93
55.74 0.566 55.55 55.28
Diluted Average Shares
0.33%
55.93
55.74 0.566 55.55 55.28
Basic Earnings Per Share
13.95%
-0.98
-0.86 -0.90 -0.79 -0.63
Diluted Earnings Per Share
13.95%
-0.98
-0.86 -0.90 -0.79 -0.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.11
price up icon 1.33%
$83.70
price down icon 1.34%
$24.42
price down icon 1.55%
$101.93
price down icon 1.05%
$134.97
price up icon 0.33%
biotechnology ONC
$297.96
price down icon 0.73%
Kapitalisierung:     |  Volumen (24h):